CoreCivic posts strong Q3 2026 with $1.34B net income, $2.2B facility sales, and $500M share buyback boost

CoreCivic reported a robust Q3 2026 with net income soaring to $1.34 billion, driven by $2.2 billion in sales of four detention facilities to the U.S. government and occupancy gains raising revenue 28.2%. The company repaid over $700 million in debt, reducing leverage significantly, and initiated a $500 million accelerated share repurchase, with the board authorizing an additional $500 million buyback. CEO Lucibeth Mayberry highlighted strong demand from ICE and the acquisition of Clinical Solutions Pharmacy as key growth drivers. CoreCivic continues managing sold facilities under government contracts and plans further activations and potential facility sales, maintaining a positive outlook for 2026.

CoreCivic's stock trades at USD 30.68 on Pluang as of Nov 05, 2026 04:12 WIB, down 0.94% in the past day. The company’s market cap stands at $3.06 billion, reflecting investor valuation after its strong Q3 results and significant debt repayment. Despite the recent share repurchase announcements, the stock remains below its 52-week high of $35.54, indicating room for market reassessment.